Sepsis: A Review of Advances in Management
dc.contributor.author | Rello, Jordi | |
dc.contributor.author | Valenzuela-Sanchez, Francisco | |
dc.contributor.author | Ruiz-Rodriguez, Maria | |
dc.contributor.author | Moyano, Silvia | |
dc.contributor.authoraffiliation | [Rello, Jordi] Vall dHebron Inst Res, CIBERES, Barcelona, Spain | |
dc.contributor.authoraffiliation | [Ruiz-Rodriguez, Maria] Vall dHebron Inst Res, CIBERES, Barcelona, Spain | |
dc.contributor.authoraffiliation | [Moyano, Silvia] Vall dHebron Inst Res, CIBERES, Barcelona, Spain | |
dc.contributor.authoraffiliation | [Valenzuela-Sanchez, Francisco] Hosp Univ Jerez, Crit Care Dept, Jerez de la Frontera, Spain | |
dc.contributor.funder | CIBERES | |
dc.contributor.funder | FISS, Instituto de Salud Carloos III, Madrid, Spain | |
dc.date.accessioned | 2025-01-07T12:53:31Z | |
dc.date.available | 2025-01-07T12:53:31Z | |
dc.date.issued | 2017-11-01 | |
dc.description.abstract | Infections represent a common health problem in people of all ages. Usually, the response given to them is appropriate and so little treatment is needed. Sometimes, however, the response to the infection is inadequate and may lead to organ dysfunction; this is the condition known as sepsis. Sepsis can be caused by bacteria, fungi or viruses and at present there is no specific treatment; its management basically focuses on containing the infection through source control and antibiotics plus organ function support. This article reviews key elements of sepsis management, focusing on diagnosis, biomarkers and therapy. The main recent advance in therapy is the strategy of personalized medicine, based on a precise approach using biomarkers to identify specific individuals who are likely to benefit from more personalized attention. | |
dc.identifier.doi | 10.1007/s12325-017-0622-8 | |
dc.identifier.essn | 1865-8652 | |
dc.identifier.issn | 0741-238X | |
dc.identifier.pmid | 29022217 | |
dc.identifier.unpaywallURL | https://europepmc.org/articles/pmc5702377?pdf=render | |
dc.identifier.uri | https://hdl.handle.net/10668/25024 | |
dc.identifier.wosID | 416262300001 | |
dc.issue.number | 11 | |
dc.journal.title | Advances in therapy | |
dc.journal.titleabbreviation | Adv. ther. | |
dc.language.iso | en | |
dc.organization | SAS - Hospital Universitario de Jerez de la Frontera | |
dc.page.number | 2393-2411 | |
dc.publisher | Springer | |
dc.rights | Attribution-NonCommercial 4.0 International | |
dc.rights.accessRights | open access | |
dc.rights.uri | http://creativecommons.org/licenses/by-nc/4.0/ | |
dc.subject | Bacteremia | |
dc.subject | Critically ill patients | |
dc.subject | Pneumonia | |
dc.subject | Sepsis | |
dc.subject | Septic shock | |
dc.subject | Critically-ill patients | |
dc.subject | C-reactive protein | |
dc.subject | Hla-dr expression | |
dc.subject | Regional pro-adrenomedullin | |
dc.subject | Goal-directed therapy | |
dc.subject | Septic shock | |
dc.subject | Immunomodulatory therapy | |
dc.subject | Antimicrobial therapy | |
dc.subject | Emergency-department | |
dc.subject | Antibiotic-therapy | |
dc.title | Sepsis: A Review of Advances in Management | |
dc.type | review | |
dc.type.hasVersion | VoR | |
dc.volume.number | 34 | |
dc.wostype | Review |